Adequacy of Antenatal Care and Its Determinants in Assiut District

August 3, 2022 updated by: Marwa Fazzaa Hassan Farag, Assiut University
Cross sectional study on women who gave birth and attend immunization session for their children in Assiut District to assess the adequacy of ANC, its determinants and knowledge and attitude of antenatal care among the studied women

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The World health organization (WHO) estimated that worldwide in 2021, about 211 women died per 100,000 live birth from pregnancy related causes and increasing to 415 on average in the poorest countries (1)Globally in 2020, nearly 2.4 million babies died during the first 28 days of life (2). High coverage of quality Antenatal Care (ANC) can play a crucial role to decrease maternal and child mortality rates and achieve national and global targets related to maternal and child health. ANC received from skilled provider increases maternal and newborn survival and reduces the risk of pregnancy complications and adverse pregnancy outcomes(3) .

New WHO guidelines on antenatal care for a positive pregnancy experience include:

  1. A minimum of eight contacts are recommended.
  2. Counselling about healthy eating and keeping physically active during pregnancy.
  3. Daily oral iron and folic acid supplementation
  4. Tetanus toxoid vaccination is recommended.
  5. One ultrasound scan before 24 weeks' gestation.
  6. Health-care providers should ask all pregnant women about their use of alcohol and other substances(4).

The 2016 WHO prenatal care guidelines for a healthy pregnancy experience reflect a change from the centered ANC model with a prescribed minimum of 4 ANC visits (ANC4+) to a more expanded model that emphasizes contact number, timing, and services(5). At the global and national levels, most currently available data indicate that women receive at least 4 antenatal care visits. There is very limited data on the adequacy of ANC based and their correlates on updated WHO recommendations for antenatal care(5, (6),(7)). The current study is conducted in accordance with the research plan of Public Health and Community Medicine Department- Faculty of Medicine, Assiut University.

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 49 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

This study will be carried on women gave birth and come to immunize their children aged 2 months. The selection of index mother will be done during children vaccination sessions as the high vaccination coverage in Egypt give higher opportunity for non- biased selection of the studied population.

Description

Inclusion Criteria :

women of reproductive age who gave birth

-

Exclusion Criteria:

Pregnant and menopaused women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adequacy of ANC
Time Frame: 2 years

): Adequacy of ANC among women who gave birth and attend immunization sessions for their children in Assiut District and its determinants based on receiving all the following 11 ANC items at least once:

  • adequate number of ANC visits (at least 8 ANC visits)
  • early ANC use (1st ANC booking during 1st trimester)
  • Provision of ANC by a skilled provider (doctor or trained nurse).
  • Measurement of blood pressure
  • A blood sample was taken
  • urine sample was taken
  • Receiving tetanus toxoid
  • Weight measurement
  • Ultrasound was performed
  • Being informed about danger signs of pregnancy
  • And receiving health education about nutrition and prescription oral iron and folic acid supplements.
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Investigators

  • Principal Investigator: Mahmoud Attia, Professor, Assiut Universiyy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2022

Primary Completion (Anticipated)

February 1, 2023

Study Completion (Anticipated)

July 1, 2024

Study Registration Dates

First Submitted

August 1, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 5, 2022

Study Record Updates

Last Update Posted (Actual)

August 5, 2022

Last Update Submitted That Met QC Criteria

August 3, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Adequacy of ANC in Assiut

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maternal Care Patterns

Clinical Trials on no intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe